ComplianceAI GovernanceFDAFTCFINRADeep Prototype

ClearLine — AI Content Compliance Audit

Audits AI-generated marketing copy against FDA, FTC, FINRA, SEC, and HIPAA requirements. Detects unsubstantiated health claims, FINRA-prohibited return guarantees, FTC endorsement violations, missing risk disclosures, and required industry disclaimers. Each finding cites the regulation.

ClearLine — AI Content Compliance Audit preview
Open live →

What it is

The compliance pass for AI-generated marketing copy. Paste any landing page, ad creative, or email body. ClearLine identifies the words and phrases that regulators have already fined other companies for using — with the specific citation, severity, and the regulator who’d issue the finding.

What it audits

  • 5 industry profiles: Health/Supplements (FDA + FTC), Financial (FINRA + SEC), Medical Device (FDA), HIPAA-covered (HHS), General (FTC + Lanham).
  • 80+ rules spanning forbidden claim patterns:
    • FDA territory (health): “cures”, “treats”, “prevents”, “diagnoses”, “reverses aging”, “FDA approved” (supplement), “scientifically proven”, “100% safe / zero side effects”, weight-loss claims, statistical claims requiring substantiation.
    • FTC endorsement (all): doctor endorsements without material-connection disclosure, testimonials without typical-result disclosure, “verified review” labels (CFR §465.4 2024 rule), required #ad / #sponsored tags.
    • FINRA (finance): “guaranteed returns”, “risk-free”, specific dollar promises, crypto investment claims without principal-loss disclosure, “past performance” without disclaimer, “SEC-registered” misuse.
    • FDA medical device: “FDA cleared” vs “FDA approved” vs “FDA registered” precision, AI/ML diagnostic claims requiring 510(k), specific-disease detection claims.
    • HIPAA: PHI references, “we share/sell data” language, right-of-access wording.
  • In-place highlighting — every flagged span shown inline with severity color + tooltip explanation.
  • Required-disclaimer check — verifies industry-specific disclaimers are present: FDA structure/function language for supplements, past-performance disclaimer for finance, indications-for-use for medical device.

Why this shape

The FTC issued $5.4 billion in refund judgments in 2023, much of it for deceptive advertising language regulators consider obvious. Companies don’t deploy non-compliant copy on purpose — they deploy it because the marketer doesn’t know which exact phrases trip FTC §5, and the legal review queue is 3 weeks deep.

ClearLine is the auto-pass step in front of legal review. Catches 80% of issues in 30 seconds. Legal handles the remaining 20% where judgment is required.

How it ships

Single HTML file, ~30KB. Zero dependencies. The 80+ rule regex library, industry-profile system, span-overlap-aware highlighter, and required-disclaimer detector are 350 lines of vanilla JavaScript.

Open the tool →